Sean Sheridan is a principal in the Intellectual Property Practice at CRA. He provides economic and financial consulting, analysis, and expert testimony in complex intellectual property litigation. Dr. Sheridan has developed numerous damages analyses related to patent infringement, breach of contract, and trade secret misappropriation, including analyses quantifying lost profits, reasonable royalties, and unjust enrichment. He has analyzed commercial success, the economic impact of injunctions, and the economic prong of the domestic industry requirement in ITC proceedings. He has also provided financial consulting services for a variety of non-litigation purposes including transaction due diligence, license negotiations, and strategic decision‐making. The engagements he has worked on span a wide range of industries, including telecommunications, handheld mobile devices, oil and gas, pharmaceuticals and biologics, medical devices, biotechnologies, automotive technologies, computer software and hardware, insurance and financial products, consumer products, and electronic health records, among others.
Previously, Dr. Sheridan was as an assistant director at the technology transfer office at the University of Chicago, where he worked for five years. In that role he negotiated numerous licenses, collaborations and other agreements with companies ranging from Fortune 500 firms to small start-ups.
Dr. Sheridan is a frequent speaker and instructor on intellectual property valuation, and also publishes on related topics. His scientific research has been published in Genes & Development, the Proceedings of the National Academy of Sciences, and Nucleic Acids Research.
Dr. Sheridan was named to the IAM Patent 1000: The World’s Leading Patent Professionals (economic experts) in 2019.
PhD, Genetics, The University of Chicago
MBA, Finance, The University of Chicago Booth School of Business
BS, Biology, Appalachian State University